Cargando…

Identification of the atypically modified autoantigen Ars2 as the target of B-cell receptors from activated B-cell-type diffuse large B-cell lymphoma

It has been suggested that stimulation of B-cell receptors (BCR) by specific antigens plays a pathogenic role in diffuse large B-cell lymphoma (DLBCL). Here, it was the aim to screen for specific reactivities of DLBCL-BCR in the spectrum of autoantigens and antigens of infectious origin. Arsenite re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thurner, Lorenz, Hartmann, Sylvia, Bewarder, Moritz, Fadle, Natalie, Regitz, Evi, Schormann, Claudia, Quiroga, Natalia, Kemele, Maria, Klapper, Wolfram, Rosenwald, Andreas, Trümper, Lorenz, Bohle, Rainer Maria, Nimmesgern, Anna, Körbel, Christina, Laschke, Matthias W., Menger, Michael D., Barth, Stefan, Kubuschok, Boris, Mottok, Anja, Kaddu-Mulindwa, Dominic, Hansmann, Martin-Leo, Pöschel, Viola, Held, Gerhard, Murawski, Niels, Stilgenbauer, Stephan, Neumann, Frank, Preuss, Klaus-Dieter, Pfreundschuh, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Fondazione Ferrata Storti 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327713/ https://www.ncbi.nlm.nih.gov/pubmed/32675228 http://dx.doi.org/10.3324/haematol.2019.241653

Ejemplares similares

Integration of the B-Cell Receptor Antigen Neurabin-I/SAMD14 Into an Antibody Format as New Therapeutic Approach for the Treatment of Primary CNS Lymphoma
por: Bewarder, Moritz, et al.
Publicado: (2020)

The B-cell Receptor Autoantigen LRPAP1 Can Replace Variable Antibody Regions to Target Mantle Cell Lymphoma Cells
por: Bewarder, Moritz, et al.
Publicado: (2021)

Current Treatment Options in CLL
por: Bewarder, Moritz, et al.
Publicado: (2021)

B‐cell receptors of EBV‐negative Burkitt lymphoma bind modified isoforms of autoantigens
por: Bock, Theresa, et al.
Publicado: (2022)

Protection strategy against outbreak of COVID-19 at a tertiary hematology-oncology: strengths and pitfalls
por: Kaddu-Mulindwa, Dominic, et al.
Publicado: (2021)

Prolonged Course of COVID-19-Associated Pneumonia in a B-Cell Depleted Patient After Rituximab
por: Kos, Igor, et al.
Publicado: (2020)

Ars2‐containing bispecific, Fab‐ and IgG1‐format BAR‐bodies to target DLBCL cells
por: Kiefer, Maximilian, et al.
Publicado: (2022)

Impact of vincristine dose reduction on outcomes of patients with aggressive B-cell lymphoma treated with (R)-CHOP
por: Bewarder, Moritz, et al.
Publicado: (2023)

Role of Specific B-Cell Receptor Antigens in Lymphomagenesis
por: Thurner, Lorenz, et al.
Publicado: (2020)

Increased B‐cell activity with consumption of activated monocytes in severe COVID‐19 patients
por: Kos, Igor, et al.
Publicado: (2021)

Management of Extranodal Marginal Zone Lymphoma: Present and Upcoming Perspectives
por: Kaddu-Mulindwa, Dominic, et al.
Publicado: (2022)

PB2104: DOSE-DENSE CHEMOTHERAPY WITH R-CHOP-14 IN OLDER ADULTS AGED ≥80 YEARS WITH DIFFUSE LARGE B-CELL LYMPHOMA
por: Christofyllakis, K., et al.
Publicado: (2022)

Lymphocyte predominant cells detect Moraxella catarrhalis-derived antigens in nodular lymphocyte-predominant Hodgkin lymphoma
por: Thurner, Lorenz, et al.
Publicado: (2020)

Adjuvant Therapy of High-Risk (Stages IIC–IV) Malignant Melanoma in the Post Interferon-Alpha Era: A Systematic Review and Meta-Analysis
por: Christofyllakis, Konstantinos, et al.
Publicado: (2021)

Vitamin D Enhances Immune Effector Pathways of NK Cells Thus Providing a Mechanistic Explanation for the Increased Effectiveness of Therapeutic Monoclonal Antibodies
por: Christofyllakis, Konstantinos, et al.
Publicado: (2023)

Progranulin autoantibodies in systemic sclerosis and autoimmune connective tissue disorders: A preliminary study
por: Klemm, Philipp, et al.
Publicado: (2019)

Progranulin antibodies entertain a proinflammatory environment in a subgroup of patients with psoriatic arthritis
por: Thurner, Lorenz, et al.
Publicado: (2013)

Killer immunoglobulin-like receptor 2DS5 is associated with recovery from coronavirus disease 2019
por: Lesan, Vadim, et al.
Publicado: (2021)

Characterization of an HLA-restricted and human cytomegalovirus-specific antibody repertoire with therapeutic potential
por: Bewarder, Moritz, et al.
Publicado: (2020)

FDG PET/CT to detect bone marrow involvement in the initial staging of patients with aggressive non-Hodgkin lymphoma: results from the prospective, multicenter PETAL and OPTIMAL>60 trials
por: Kaddu-Mulindwa, Dominic, et al.
Publicado: (2021)

IgG seroprevalence of COVID‐19 among people living with HIV or at high risk of HIV in south‐west Germany: A seroprevalence study
por: Kaddu‐Mulindwa, Dominic, et al.
Publicado: (2021)

B-cell receptor reactivity against Rothia mucilaginosa in nodular lymphocyte-predominant Hodgkin lymphoma
por: Thurner, Lorenz, et al.
Publicado: (2023)

Radiation and Dose-densification of R-CHOP in Aggressive B-cell Lymphoma With Intermediate Prognosis: The UNFOLDER Study
por: Thurner, Lorenz, et al.
Publicado: (2023)

USP9X stabilizes XIAP to regulate mitotic cell death and chemoresistance in aggressive B‐cell lymphoma
por: Engel, Katharina, et al.
Publicado: (2016)

Radiation and Dose-densification of R-CHOP in Primary Mediastinal B-cell Lymphoma: Subgroup Analysis of the UNFOLDER Trial
por: Held, Gerhard, et al.
Publicado: (2023)

Advances in Lymphoma Molecular Diagnostics
por: Kos, Igor Age, et al.
Publicado: (2021)

Autoantibodies against SUMO1-DHX35 in long-COVID
por: Thurner, Lorenz, et al.
Publicado: (2022)

Rituximab retherapy in patients with relapsed aggressive B cell and mantle cell lymphoma
por: Borgerding, Andrea, et al.
Publicado: (2009)

The impact of SOCS1 mutations in diffuse large B‐cell lymphoma
por: Mellert, Kevin, et al.
Publicado: (2019)

Gene expression profiling reveals a close relationship between follicular lymphoma grade 3A and 3B, but distinct profiles of follicular lymphoma grade 1 and 2
por: Horn, Heike, et al.
Publicado: (2018)

Age-dependent increase of treatment-related mortality in older patients with aggressive B cell lymphoma: analysis of outcome, treatment feasibility, and toxicity in 1171 elderly patients with aggressive B cell lymphoma—data from phase II and III trials of the DSHNHL (German High-Grade Non-Hodgkin’s Lymphoma Study Group)
por: Zettl, Florian, et al.
Publicado: (2020)

Landscape of 4D Cell Interaction in Hodgkin and Non-Hodgkin Lymphomas
por: Hartmann, Sylvia, et al.
Publicado: (2021)

A 70% cut-off for MYC protein expression in diffuse large B-cell lymphoma identifies a high-risk group of patients
por: Ziepert, Marita, et al.
Publicado: (2020)

A modular transcriptome map of mature B cell lymphomas
por: Loeffler-Wirth, Henry, et al.
Publicado: (2019)

Non-Invasive Bioluminescence Imaging to Monitor the Immunological Control of a Plasmablastic Lymphoma-Like B Cell Neoplasia after Hematopoietic Cell Transplantation
por: Chopra, Martin, et al.
Publicado: (2013)

The riddle of lymphoma BCR-antigenes
por: Thurner, Lorenz, et al.
Publicado: (2018)

Prevalence of Anti-Citrullinated Protein Antibodies (ACPA) in Patients with Diffuse Large B-Cell Lymphoma (DLBCL): A Case-Control Study
por: Assmann, Gunter, et al.
Publicado: (2014)

Indeterminate Dendritic Cell Tumor With Persistent Complete Metabolic Response to BRAF/MEK Inhibition
por: Thurner, Lorenz, et al.
Publicado: (2020)

Fewer neurocognitive deficits and less brain atrophy by third ventricle measurement in PLWH treated with modern ART: A prospective analysis
por: Kaddu-Mulindwa, Dominic, et al.
Publicado: (2022)

Global gene expression changes of in vitro stimulated human transformed germinal centre B cells as surrogate for oncogenic pathway activation in individual aggressive B cell lymphomas
por: Schrader, Alexandra, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ohm7da6pajohm5htljpjt2lhlg